Trials / Recruiting
RecruitingNCT05433935
Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
A Prospective, Open Large Cohort Study of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- 0 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective, open large cohort study to explore biomarkers for detecting early carcinogenesis of IPMN.
Detailed description
This prospective study was designed to explore biomarkers for detecting early carcinogenesis of IPMN. This study intends to prospectively and continuously enroll IPMN patients, and regularly collect biological samples including blood, urine, feces and saliva. We aimed to detect biomarkers which can predict the carcinogenesis of IPMN by multi-omics. The primary endpoint is the predictive accuracy of biomarkers for IPMN malignant transformation. The probability of IPMN malignant transformation , rates of surgical resection and survival after surgery are secondary endpoints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observation | This is an observational study. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2032-06-30
- Completion
- 2033-12-31
- First posted
- 2022-06-27
- Last updated
- 2023-01-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05433935. Inclusion in this directory is not an endorsement.